Evaluation of ischemia modified albümin levels in patients diagnosed with acute kidney failure after and before the treatment
Mehmet Uzun1, Emin Taşkıran1, Burak Karakaş1, Mehmet Tanrısev1, Yusuf Kurtulmuş2, Mustafa Yıldırım1, Semih Gülle1, Harun Akar1
1Tepecik Eğitim ve Araştırma Hastanesi, İç Hastalıkları Kliniği, İzmir, Türkiye
2Tepecik Eğitim ve Araştırma Hastanesi, Biyokimya Kliniği, İzmir, Türkiye
Keywords: Dialysis; ischemic modified albumin; kidney failure.
Abstract
Objectives: Our aim was to answer the question of Is there a statistically significant relationship between plasma ischemia modified albumin (IMA) levels of acute kidney failure (AKF) patients before the hospital admission and their clinical healing progress.
Patients and methods: Between August 2014 and October 2014, we included 18 patients (9 males, 9 females) who were diagnosed with AKF and investigated the relationship between patients’ blood levels of IMA before admission to the hospital and clinical progress.
Results: Plasma IMA average of 18 patients before treatment was 628. After treatment plasma IMA average was 428. A statistically reasonable relationship was detected.
Conclusion: Our study suggest that hospital stay of patients who had higher plasma levels of IMA was remarkably longer than who had lower plasma levels of IMA. Also we detected that the more plasma levels of IMA increased, the need of patients’ for hemodialysis increased.